恒瑞医药_花旗 2025 中国峰会新动态_中国创新药推动下的全球布局

Flash | 16 Nov 2025 18:02:32 ET │ 11 pages Jiangsu Hengrui Pharmaceuticals (600276.SS) What's New from Citi 2025 China Conference: Global Deployment amid China's Innovative Drugs Push CITI'S TAKE At the Citi China Conference 2025, we invited Hengrui's President & COO Ji Feng to give a talk on China's innovative drug industry developments and Hengrui's role in it. Ms. Feng talked about the opportunities and challenges for China innovative drugs, and the global deployment of Hengrui Pharma. Ms. Feng noted tha ...